Low-Dose Aspirin Prophylaxis to Prevent Preeclampsia

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Public Health

Background:

• Hypertensive disorders in pregnancy, such as pre-eclampsia, are significant contributors to maternal and infant mortality worldwide.
• Low-dose aspirin has demonstrated efficacy in pre-eclampsia prevention over decades of research.
• Despite established benefits, there remains a gap in the clinical application of low-dose aspirin for high-risk pregnancies.

Purpose of the Study:

• To review the evidence supporting low-dose aspirin for pre-eclampsia prevention.
• To examine professional organization recommendations regarding its use.
• To identify disparities between recommendations and clinical practice, and discuss implications.

Main Methods:

• Literature review of evidence for low-dose aspirin in pre-eclampsia prevention.
• Analysis of current professional organization guidelines and recommendations.
• Assessment of the gap between guidelines and clinical implementation.
• Discussion of research, practice, and policy implications.

Main Results:

• Substantial evidence supports low-dose aspirin's role in preventing pre-eclampsia.
• Professional organizations recommend low-dose aspirin for high-risk pregnancies.
• A significant gap exists between these recommendations and actual patient use.
• Barriers to implementation require further investigation and targeted interventions.

Conclusions:

• Low-dose aspirin is a vital tool for preventing pre-eclampsia and improving maternal-fetal outcomes.
• Addressing the gap between recommendations and practice is crucial for public health.
• Future research and policy updates should focus on facilitating wider adoption of low-dose aspirin therapy.